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Abstract
Background: Down-regulation of plasma membrane receptors via the endocytic pathway involves
their monoubiquitylation, transport to endosomal membranes and eventual sorting into multi
vesicular bodies (MVB) destined for lysosomal degradation. Successive assemblies of Endosomal
Sorting Complexes Required for Transport (ESCRT-I, -II and III) largely mediate sorting of plasma
membrane receptors at endosomal membranes, the formation of multivesicular bodies and their
release into the endosomal lumen. In addition, the human ESCRT-II has been shown to form a
complex with RNA polymerase II elongation factor ELL in order to exert transcriptional control
activity.
Results: Here we report the crystal structure of Vps25 at 3.1 Å resolution. Vps25 crystallizes in
a dimeric form and each monomer is composed of two winged helix domains arranged in tandem.
Structural comparisons detect no conformational changes between unliganded Vps25 and Vps25
within the ESCRT-II complex composed of two Vps25 copies and one copy each of Vps22 and
Vps36 [1,2].
Conclusions: Our structural analyses present a framework for studying Vps25 interactions with
ESCRT-I and ESCRT-III partners. Winged helix domain containing proteins have been implicated in
nucleic acid binding and it remains to be determined whether Vps25 has a similar activity which
might play a role in the proposed transcriptional control exerted by Vps25 and/or the whole
ESCRT-II complex.
Background
Endosomal compartments receive membrane bound
cargo from both the biosynthetic and the endocytic path-
ways. Receptor downregulation by endocytosis includes
transport to early endosomes and either recycling or sort-
ing into late endosomes. The latter have the morphologi-
cal characteristics of multivesicular bodies (MVB) [3] that
can undergo homotypic fusion or heterotypic fusion with
lysosomes, which deliver MVB cargo for proteolytic degra-
dation [4]. In addition to receptor downregulation, MVB
formation has been implicated in antigen presentation [5]
and in the release of enveloped viruses [6,7].
Gene deletion and inactivation studies in yeast have iden-
tified 17 proteins that directly affect MVB formation (yeast
class E compartment) by resulting in aberrant endosomal/
vacuolar morphology [4]. All proteins are required for vac-
uolar protein sorting (VPS) into the class E compartment
and are recruited to endosomal membranes from the
cytosol in order to assemble into three ESCRT (Endosomal
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Sorting Complexes Requited for Transport) complexes that
function in MVB formation [8-11]. Receptor mono-ubiq-
uitinylation has been shown to serve as a signal to enter
the MVB pathway [12]. Initial recognition of ubiquiti-
nated cargo by Vps27 recruits the ubiquitin binding pro-
tein Vps23 [11,13], which in turn leads to the assembly of
the multi-protein complex ESCRT-I (VPS23, VPS28, and
VPS37) [10]. ESCRT-I subsequently recruits ESCRT-II,
composed of Vps22, Vps25, and Vps36, which in turn
activates ESCRT-III subcomplexes [8,9]. Assembly of
ESCRT-III at the endosome initiates the sorting and con-
centration of ubiquitinated cargo; ubiquitin is removed
and Vps4, an AAA-type ATPase, dissociates the ESCRT
complexes concomitantly with membrane invagination
and budding of vesicles into the lumen of the endosome
[4].
Two recent crystal structures of a core of the ESCRT-II
complex reveal a trilobal complex, containing two copies
of Vps25, one copy of Vps22 and the C-terminal region of
Vps36. Each subunit is composed of two winged helix
domains and an N-terminal region of Vps25 interacts
with Vps22 and Vps36 [1,2].
Although ESCRT-II is essential for the MVB pathway, since
cells missing ESCRT-II components fail to localize ESCRT-
III to late endosomes [8,9] the complex has also been
found "moonlighting" in the nucleus. The human and rat
homologues of ESCRT-II were originally identified as the
EAP complex (ELL Associating Protein; Vps22/EAP30;
Vps25/EAP20; Vps36/EAP45), associated with the RNA
polymerase II elongation factor ELL in the nucleus
[14,15]. Consistent with a role in transcriptional control,
yeast Vps22 (or SNF8) as well as Vps25 and Vps36 have
been implicated in glucose-dependent gene expression
control [15,16]. To date, it is not clear whether the role of
ESCRT-II in MVB formation is independent of its function
as a transcriptional activator or whether both processes
are linked. Here, we report the crystal structure of full-
length yeast Vps25, composed of two homologous
winged-helix domains.
Results and discussion
Structure of Vps25
The structure of Vps25 was solved by single wavelength
anomalous diffraction (SAD) using selenomethionine-
derivatized crystals. Vps25 consists of two homologous
winged helix domains as detected by the program GRATH
http://www.ebi.ac.uk/services/ that are arranged in tan-
dem (Figure 1A). Winged helix folds are compact alpha/
beta structures with secondary structure elements
arranged in a typical order (H1-S1-H2-H3-S2-W1-S3-
W2optional) [17], which fold into a mostly helical part fol-
lowed by a twisted anti-parallel beta-sheet and two large
loops (wings, W). The fold of Vps25 deviates slightly from
the canonical fold. The N-terminal domain 1 (residues 1
to 126) contains two additional N-terminal 3/10 helices,
implicated in the interaction with either Vps22 or Vps36
[1,2], followed by the canonical helix 1 and strand 1. It
lacks canonical helix 2, which instead folds into a large
disordered loop followed by strands 3 and 4 that connects
to helix 2 (at the corresponding position of canonical
helix 3). Strands 5 and 6 then form, together with strand
1, a twisted anti-parallel beta-sheet with wing W1 protrud-
ing from the structure (Figure 1A and Figure 2). Domain
1 also lacks wing W2, as in the cases of winged helix
domain containing transcription factors E2F4 and DP2
[18]. Strand 6 flows directly into domain 2, which also
has a canonical winged helix fold except for the absence of
wing W2 (Figure 1A and Figure 2). Domains 1 and 2 are
tightly packed against each other and their C alpha atoms
can be superimposed with an r.m.s. deviation of 3.4 Å
(Figure 1B), confirming their structural relatedness. The
domain interface is dominated by van der Waals contacts
including conserved and non conserved residues Trp44,
Phe122, Leu104, Leu124, Trp125 in domain 1 and
Leu128, Trp131, Met168, Pro169 and Leu172 in domain
2 (Figure 2).
Structural comparision of unliganded Vps25 and Vps25 in 
complex with Vps22 and Vps36 (ESCRT-II)
Two recent crystal structures of the ESCRT-II core reveal
trilobal structures with head to tail interactions of one
copy of Vps25 with Vps22 and the other copy of Vps25
with Vps36 at the center. In both cases a conserved proline
rich N-terminal region of Vps25 (Figure 2) together with
conserved Arg83 mediate key interactions [1,2]. Therefore
it was of interest to analyse whether Vps25 undergoes any
conformational changes upon participation in ESCRT-II
complex formation. Superposition of the C alpha atoms
with one copy of Vps25 from either ESCRT-II complex
structure ([1,2]; pdb entries 1U5T and 1W7P) revealed r.
m. s. displacements of 1.2/1.2 Å (residues 3 to 51), 1.5/
1.7 Å (residues 74 to 155) and 2.3/2.9 Å (residues 159–
199) respectively. The major changes are confined to both
wings W1 and W2 indicating their conformational flexi-
bility (Figure 3). In contrast, the conserved N-terminal
segment, which is implicated in Vps22 and Vps36 interac-
tions shows no substantial changes (Figure 3).
In the unliganded Vps25 structure, this helical segment
constitutes the 1192 Å2 dimerization interface of two
identical Vps25 dimers present in the asymmetric crystal
unit. The dimer contact is mediated by hydrophobic resi-
dues Pro5, Pro6, Val7, Phe10, Pro11, and Pro12, which is
similar to the contact region described for Vps25 interac-
tions with Vps22 and Vps36 [1,2]. In the Vps25 structure
Arg83 does not participate in dimerization but hydrogen
bonds to Thr15 instead of forming salt bridges with either
Vps36 Asp548 or Vps22 Asp214 as observed in theBMC Structural Biology 2004, 4:10 http://www.biomedcentral.com/1472-6807/4/10
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ESCRT-II complex [1,2]. Arg83 locates to a beta hairpin
(strand 4; Figure 2) in the unliganded form of Vps25.
Although the position of Arg83 is unchanged in all Vps25
structures (Figure 3) the position of the preceding loop
region varies which might be due to differences in second-
ary structure assignment [1,2]. Therefore Vps25 seems to
dock as a rigid body onto either Vps22 or Vps36 upon
ESCRT-II complex formation. Although we do not detect
Vps25 dimer formation in vitro, a dimeric form of Vps25
might be stabilized through other unknown interactions.
Structural homology of Vps25 with nucleic acid binding 
winged helix domains
Analysis of the full-length structure with DALI [19]
revealed seven structural homologues displaying nucleic
acid binding winged helix domains with a Z score above
5 for Vps25 domain 1. The top two hits were the seleno-
cysteine-specific elongation factor fragment (PDB 1lva, Z
score 6) and double-stranded RNA specific adenosine
deaminase (ADAR) Z-alpha domain (PDB 1qbj, Z score
5.5). Winged helix family members interact with nucleic
acids mostly via the "specificity helix" that binds to the
major groove of the DNA with two flanking loops contrib-
uting to DNA interactions [17]. Superposition of Vps25
domain 1 onto the winged helix domain of E2F-4 bound
to DNA [18] matching the "specificity helices" (Vps25
helix H2) revealed a potential fit with only minor clashes
at the helix H1 loop region (data not shown). A potential
nucleic acid interaction of Vps25 might be interesting in
light of the described role of Vps25 and the other ESCRT-
II subunits in glucose-dependent gene regulation [15,16]
and complex formation with RNA polymerase II elonga-
tion factor ELL [14,15], although no biochemical data
exist so far to support such a proposed function.
Vps25 participates in protein complex formation
The ESCRT-II complex assembles at the endosomal mem-
brane downstream of ESCRT-I and recruits ESCRT-III sub-
complexes [8-10]. Consistent with such a sequential
assembly, further ESCRT-II interactions of Vps25 have
been described, namely with Vps28 (ESCRT-I) and with
Vps20 (CHMP6; ESCRT-III) [7,20]. Surface electrostatic
potential maps of Vps25 reveal a negatively charged sur-
face within domain 2 that is characterized by a patch of
conserved residues such as Glu153, Glu170 and Tyr152
(Figure 4A and Figure 2). Tyr152 is also part of the highly
conserved domain 2, helix 4 (Figure 2). Domain 2 is the
outer domain of Vps25 in the ESCRT-II complex and this
region would thus be freely accessible for potential inter-
action(s) with Vps28 or Vps20. Similarly, basic residues
(Lys99 and Arg23) potentially implicated in nucleic acid
recognition are part of a conserved patch on domain 1
(Figures 4B and 2).
Vps25 contains additional features, which are unique to S.
cerevisiae, as evidenced from multiple sequence analysis
[15,16]. Vps25 orthologues have a shorter strand 2 to
strand 3 connection (19 residues), whose sequence is
composed of mostly charged residues and is disordered in
our structure as well as in the ESCRT-II structures [1,2].
Furthermore, domain 1 wing W1 is shorter (7 residues)
(Figure 2), which might indicate S. cerevisiae unique pro-
tein-protein interaction sites.
Vps25 contains two winged helix domains arranged in  tandem Figure 1
Vps25 contains two winged helix domains arranged 
in tandem. (A) Ribbon diagram of Vps25; the two domains 
are shown in orange and yellow. Secondary structure ele-
ments are labeled. The major missing loop region connecting 
strands 1 and 3 is indicated by a dashed line. (B) Superposi-
tion of the Calpha positions of the N- and C-terminal 
domains (residues 23 to 48 and 85 to 101 with correspond-
ing C-terminal domain residues; r.m.s.d. 3.4 Å). Note that the 
positions of helices 1/3 and helices 2/5 as well as wing posi-
tions W1 match up well.BMC Structural Biology 2004, 4:10 http://www.biomedcentral.com/1472-6807/4/10
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Conclusions
Clear evidence suggests that ESCRT-II recruitment is
involved in MVB formation leading to plasma membrane
receptor downregulation [4]. On the other hand ESCRT-II
seems to play a role in transcription regulation [15]. Sim-
ilarly, other ESCRT components such as Tsg101 (Tumor
susceptibility gene; Vps23; ESCRT-I) and members of the
CHMP protein family (ESCRT-III; Chromatin  Modifying
Protein; Charged Multivesicular body Protein) are also found
to act in the nucleus as well as in the cytosol and at endo-
somal membranes [21-23]. Interestingly, both Vps25 and
Vps36 have been implicated in regulating stress and phe-
romone response pathways [24] and pheromone receptor
Ste2 is downregulated via the endosomal pathway [12].
Similarly, SNF8 (Vps 22; EAP30), Vps36 and Vps25 are all
directly involved in derepression of glucose-repressed
genes, which might be linked to sorting of sucrose recep-
tors via the endosomal pathway [15,25]. Protein sorting
into MVB involves monoubiquitylation of cargo, which is
recognized by ESCRT members. ESCRT-II Vps36 contains
Structure based sequence alignment of Vps25 Figure 2
Structure based sequence alignment of Vps25. Sequences aligned using S. cerevisiae Vps25 (gene bank #CAA89632) and 
Vps25 orthologues from H. sapiens (#BE386260), D. melanogaster (#AAF59066) and from C. elegans (#T26073). Identical resi-
dues are shown on red background, similar residues are drawn in red and sequence similarity is underlined by blue boxes. Sec-
ondary structure elements are shown. Disordered regions in the Vps25 structure are indicated by dashed lines.BMC Structural Biology 2004, 4:10 http://www.biomedcentral.com/1472-6807/4/10
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an ubiquitin binding NZF zinc finger motif that is
necessary for protein sorting [26]. Therefore, ESCRT-II
complexes may sense the turnover of specific ubiquit-
ylated receptors at the endosomal membrane together
with other unknown signals. As ESCRT-II only transiently
associates with endosomal membranes [9] a signal within
the MVB process might induce nuclear localization of
ESCRT-II, where it could stimulate gene expression lead-
ing to up or down regulation of specific membrane
receptors.
Methods
Protein expression, purification and crystallization
Full length yeast Vps25 DNA (gene bank #CAA89632)
was cloned into expression vector pETM30 (EMBL, Pro-
tein Expression Facility) and the Vps25 GST fusion pro-
tein was expressed in E. coli BL21 codon+ cells. For
purification, cell pellets from 6 liter cultures were lysed in
150 mls of buffer A (50 mM Tris-HCl, pH 8.5, 200 mM
NaCl, 0.2 mM DNaseI, 2 mM β-ME, 2 complete EDTA-free
protease inhibitor tablets (Pierce)) and 0.1 mg/ml lys-
ozyme for one hour on ice. The cell lysate was cleared by
centrifugation and loaded onto a GST-sepharose (Phar-
macia) column. The column was extensively washed with
buffer B (50 mM Tris pH 8.5, 200 mM NaCl) and Vps25
fusion protein was eluted with buffer B containing 5 mM
reduced glutathione. GST was then removed by TEV cleav-
age (w/w; 1:200) at 4°C overnight. His-tagged GST and
TEV were subsequently both removed on a Ni2+ chelating
sepharose column. Vps25 was further purified on a
superdex75 column (Pharmacia) in buffer C (50 mM Tris
8.5, 200 mM NaCl, 2 mM βME). Selenomethione-labeled
Vps25 was produced using standard procedures and puri-
fied as described above.
Crystallization conditions for Vps25 (7 mg/ml) were first
determined by screening 600 conditions using a Cartesian
crystallization robot. Initial conditions were refined using
the hanging drop method, and the final crystallization
condition (100 mM Na cacodylate pH 6.5, 200 mM Mg or
Ca acetate, 5–7% glycerol, and 15–18% polyethylene gly-
col 8000) produced rectangular- and wedge-shaped
Comparison of unliganded and liganded Vps25 Figure 3
Comparison of unliganded and liganded Vps25. Super-
position of unliganded Vps25 (red) with Vps25 from both 
ESCRT-II structures [1, 2] (blue, pdb code 1U5T chain C; 
green, pdb code 1W7P chain B). The peptide backbones are 
shown as coils. Vps25 is shown in the same orientation as in 
figure 1A. The position of Arg83 is indicated by an arrow.
Surface charge distribution of Vps25 Figure 4
Surface charge distribution of Vps25. (A) Surface 
potential representation of Vps25 with regions where elec-
trostatic potential <-10 kBT are red, while those >+10 kBT 
are blue (kB, Boltzmann constant; T, absolute temperature). 
(B) Horizontal rotation (180°). Exposed residues are labeled 
for orientation. Note that one face of the molecule carries a 
mainly negative charge (A) while the other one carries a 
mainly positive charge (B).BMC Structural Biology 2004, 4:10 http://www.biomedcentral.com/1472-6807/4/10
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selenomethionine-labeled Vps25 crystals in the same
drop. Native Vps25 crystallized initially only with rectan-
gular morphology and wedge-shaped crystals were pro-
duced by microseeding with the original SeMet crystals.
For cryogenic data collection, the crystals were equili-
brated in 25% glycerol and flash cooled in a gaseous
nitrogen stream at 100 K.
Crystallization produced rectangular crystals that belong
to space group P422 with unit cell dimensions a = b = 78
Å, c = 54 Å and diffract to 3.2 Å resolution. However, all
data sets collected from these crystals proved to be almost
perfectly merohedrally twinned. The second crystal form,
wedge-shaped, belonged to space group P212121 with unit
cell dimensions as indicated (table 1), contained 4
molecules per asymmetric unit, diffracted X-rays to 3.1 Å
resolution and was used for structure solution.
Data Collection
Native data for Vps25 were collected at the European Syn-
chrotron Radiation Facility (ESRF) beamline ID14-EH3
and data from SeMet-labeled crystals were collected at the
ESRF beam line ID29 at three wavelengths (table 1). Data
were processed and scaled with XDS [27].
Phasing and refinement
Significant radiation damage had occurred for data col-
lected at the inflection and remote wavelengths, therefore
only data collected at the peak wavelength (table 1) were
used for SAD phasing. ShelXD [28] was used to find 14
out of 16 selenium sites, which were further refined with
SOLVE [29]. Four-fold non-crystallographic symmetry
was imposed on the sites in addition to solvent flattening
with RESOLVE [30]. Phasing statistics are listed in table 1.
The initial model was built with O [31] guided by the
SeMet positions and clear tryptophan (7 per mol) and
tyrosine (8 per mol) densities followed by refinement
with CNS [32]. Strict four-fold NCS and phases were
initially kept throughout the initial chain-tracing and
refinement. During model building it was observed that
molecules A and B and molecules C and D are arranged in
the same dimer configuration and strict NCS was changed
to restrained NCS during refinement. The packing also
indicated tight interactions between molecules A, B, and C
while molecule D showed only very few crystal contacts
yet formed the "bridge" between two-dimensional layers
formed by molecules A, B and C. The electron density
maps for molecules A, B, and C were clear and well
defined, while electron density for molecule D was poorly
defined for side chains and loops. The model was
improved by alternating cycles of model building and
Table 1: Data Collection and Refinement.
Crystal VPS25-SEMET VPS25-NATIVE
Space Group P212121 P212121
Wavelength 0.97914 0.931
Unit Cell (Å)
a 53.44 53.36
b 124.11 123.66
c 139.48 140.30
Resolution (outer shell) (Å) 100-3.20 (3.31-3.20) 100 - 3.10 (3.21-3.10)
Total Reflections (outer shell) 111407 (10016) 65477 (6064)
Unique Reflections 29230 16330
Completeness (%) (outer shell) 98.9 (93.1) 93.1 (91.3)
Rmerge (outer shell) 0.090 (0.335) 0.053 (0.307)
Average I/sigma (outer shell) 12.3 (4.9) 20.9 (4.9)
Phasing
Number of Se Sites 14
SOLVE FOM 0.351
RESOLVE FOM (ncs) 0.694
Refinement
Resolution (outer shell) (Å) 25.0-3.10 (3.29-3.10)
Number of reflections (test set) 16404 (790)
R factor 0.275
Free R factor 0.327
Number of protein/solvent atoms 5760/16
Average B factor (Å2)5 1 . 3
Rms deviation bond lengths (Å) 0.009
Ramachandron Mol A Mol B MolC MolD
Most favored
Additionally favored
83.8
15.7
79.5
20.5
82.1
17.9
67.2
32.8BMC Structural Biology 2004, 4:10 http://www.biomedcentral.com/1472-6807/4/10
Page 7 of 8
(page number not for citation purposes)
conjugate gradient minimization and restrained individ-
ual B-factor refinement using CNS [32]. The final coordi-
nates were refined against the native dataset (30 to 3.1 Å)
using the MLHL maximum likelihood target with the
RESOLVE phases as constraint and retaining the original
test set reflections. In the final stage of refinement, a max-
imum likelihood target and model phases alone were
used.
The final model lacks two to five flexible loops (molecule
mol A, residues 56–72, 114–115, 156–157; mol B,
residues 53–73, 157–158; mol C, residues 57–72, 155–
158; mol D, residues 19–21, 55–73, 107–120, 156–160,
185–186). Accordingly, mol D is poorly defined (43 resi-
dues missing out of 204). The final R factor and R free
(0.275/0.327) reflect missing residues and the poor
model for molecule D. The model exhibits otherwise
overall good stereochemistry with no outliers in the Ram-
achandran plot as defined in PROCHECK (table 1) [33].
The coordinates have been deposited in the RCSB Protein
Data Bank accession code 1XB4 [PDB:1XB4].
Structure analysis
Figures were generated using coordinates of molecule C
with programs MOLSCRIPT [34], Raster 3D [35], ESPript
[36], GRASP [37] and PyMOL http://www.pymol.org.
Sequences were aligned using Clustalx [38]. Secondary
structure elements were assigned using the program DSSP
[39]. The buried surface was calculated with CNS [32] and
the program LSQMAN was used for superpositioning of
C-alpha positions [40].
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